Dr. Ciaran P. Kelly, MD

Dr. Kelly practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Kelly's NPI, 1851406813, was assigned on August 20, 2006. Dr. Kelly holds Massachusetts license 74719.

Dr. Kelly's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Kelly's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Kelly is also affiliated with Beth Israel Deaconess Hospital-Milton. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelly practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kelly's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kelly is licensed in Massachusetts.

CMS data shows 120 Medicare services from Dr. Kelly across 6 procedure codes in 2024, for 109 Medicare patients. Medicare paid $5,529 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 109 Medicare patients who saw Dr. Kelly in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kelly's median patient age at 54, with 64% women.

In 2024, Dr. Kelly wrote 104 Medicare Part D claims for 45 patients. 72% of them were for generic drugs. CMS names the drug for 55 of them, across 3 drugs with 11 or more claims each, at $19,069 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Kelly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kelly as offering telehealth.

Dmand AI links 2 papers to Dr. Kelly in 2023. The most frequent topics are ST Elevation Myocardial Infarction. Dr. Kelly's most frequent co-authors are Christopher Reid, MD and Carl Schultz, DO.

CMS Open Payments shows 148 general payments to Dr. Kelly from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Merck Sharp & Dohme Corporation paid the most, $109,320. It also lists 1 research payment totaling $2,310 in 2025.